Navigation Links
OncoSec Medical Announces $7.2 Million Public Offering
Date:12/13/2012

SEC's website at www.sec.gov or by request at Dawson James Securities, Inc. by e-mailing placements@djsiny.com.

This announcement is neither an offer to sell nor a solicitation of an offer to buy any of OncoSec's common stock or warrants. No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.

About OncoSec Medical Inc.

OncoSec Medical Inc. is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers. ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives.  OncoSec Medical's core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. More information is available at http://www.oncosec.com/.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's cu
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
7. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
8. OncoSec Granted New Patent from China
9. OncoSec to Present at Upcoming Healthcare and Investor Conferences
10. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
11. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... DUBLIN , June 26, 2015 ... of the "Vitamin D Market by Analog, Application, End-User ... report to their offering. This market is ... use of vitamin D in different applications and rising opportunities ... China , Italy , and ...
(Date:7/2/2015)... , July 2, 2015 Numotion,s Board of ... announced that Tamas Feitel has joined the ... Numotion after a highly successful 18 year career at ... driving strategy, profitability, and productivity to result in significant ... position was Chief Financial Officer for GE Healthcare Global ...
(Date:7/2/2015)... The report "Silage Inoculants & Enzymes Market ... Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type & Geography - ... Enzymes Market is expected to reach $489.05 Million by ... 2020. Browse 75 market Tables and ... P ages and an in-depth TOC on ...
Breaking Medicine Technology:Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3Numotion Names Tamas Feitel Chief Financial Officer 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4
... IRVINE, California , and AMSTERDAM , ... molecular cancer diagnostics, announced today that company,CEO Dr. Bernhard ... July 20 ,in Washington D.C. on the ... Food and Drug Administration (FDA) and,Center for Devices and Radiological ...
... , DETROIT , July 15 Caraco Pharmaceutical ... July 12, 2010 , NYSE Amex notified the Company that it ... standards that its audit committee be comprised of three independent members. ... of its non-compliance with Section 803(B)(2)(a) of NYSE Amex Company Guide ...
Cached Medicine Technology:Agendia to Provide Testimony at Public Meeting on FDA Oversight of Laboratory-Developed Tests 2Caraco Pharmaceutical Laboratories, Ltd. Receives Notice Regarding NYSE Amex Continued Listing Standards 2
(Date:7/3/2015)... ... ... will hopefully be getting a large donation of canned food items at the end ... making it their mission to collect as many canned items as possible. Donations do not ... as well. As part of the canned food drive, these local chiropractors will be donating ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top ... mesothelioma with even minimal asbestos exposure. Click here to read the complete story ... of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed mice ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County ... 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William ... practical points of investigating these types of cases. , Each year, New York ...
(Date:7/3/2015)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... Director of its Frisco facility. , “We are pleased to announce that Dr. Manzanares ... Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Manzanares received ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... The Celebrity ... or cocktail dresses similar to those of celebrities will have the opportunity to get ... at checkout. This ensures that people do not have to use coupon codes or ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2
... fall season can be just as bad as the ... over-the-counter (OTC) medicine; however, can quickly becoming an// overwhelming ... shelf of products that often times have very similar ... pharmacy of the Philadelphia College of Pharmacy at University ...
... the American Heart Association's 60th Annual Fall Conference of the ... high blood// pressure may be at risk of sleep breathing ... high blood pressure, 60 % of whom were affected by ... upper airway obstructions cause SDB. These obstructions can be complete ...
... new front in the war against flu, researchers at ... a novel compound that confers broad protection// against influenza ... work, reported online this week (Oct. 4, 2006) in ... peptide -- a small protein molecule -- that effectively ...
... that reviews of drugs, which are supported by the ... conclude// sympathetically as compared to independent reviews, reveals a ... that bias in drug trials is a common phenomenon ... which can have a more unbiased and systematic approach ...
... 20 Cuban deaf and blind children can hear now, ... has revolutionized the world of profound// neuro-sensorial auditory deficiency. ... International Health Centre in Havana, the Prensa Latina news ... speaking signs into electric signals, partially restoring the hearing ...
... premier hospital, the All India Institute of Medical Sciences (AIIMS), ... and garbage littered across the campus. ,In the last ... exposed serious flaws within India's best known public health facility ... 26 resident doctors, medical students and staff being admitted to ...
Cached Medicine News:Health News:Allergy OTC Medicines–Speak With Your Pharmacis 2Health News:Allergy OTC Medicines–Speak With Your Pharmacis 3Health News:Hypertensive Kids at risk of sleep disordered breathing 2Health News:Hypertensive Kids at risk of sleep disordered breathing 3Health News:New Drug Blocks Influenza, Including Bird Flu Virus 2Health News:New Drug Blocks Influenza, Including Bird Flu Virus 3Health News:AIIMS Campus - A Breeding Ground for Mosquitoes 2Health News:AIIMS Campus - A Breeding Ground for Mosquitoes 3
... The Spectrum® Tissue Repair System is designed ... and shoulder soft tissue. It features ... roller system. Interchangeable suture hooks allow ... The Spectrum® Tissue Repair System is ...
... The Mini-Open Rotator Cuff Repair ... by,reducing procedure time, incision size and ... system,augments other rotator cuff repair systems ... of,three sizes of matched cortical gauge ...
Threaded cannula with cannulated obturator for use with Acufex Suture Punch; sterile packs, box of 10....
Threaded cannula for use with Suretac® II, sterile packs, box of 10....
Medicine Products: